|
ZEN-3694 presentation at 28th EORTC-NCI-AACR SYMPOSIUM
|
3
|
Zenith Epigenetics
|
Oct 03, 2016 12:39PM
|
|
ZEN-3694 mCRPC Trial Status
|
6
|
Zenith Epigenetics
|
Oct 24, 2017 11:18AM
|
|
ZEN-3694 mCRPC trial no longer recruiting
|
2
|
Zenith Epigenetics
|
Apr 30, 2019 05:14PM
|
|
ZEN-3694 level up
|
2
|
Zenith Epigenetics
|
Oct 05, 2016 02:24PM
|
|
ZEN-3694 & Enzalutamide Combo Trial Now Recruiting
|
2
|
Zenith Epigenetics
|
Dec 06, 2016 04:31PM
|
|
Zacks SCR Resverlogix Report 12/28/18
|
3
|
Resverlogix Corp.
|
Jan 02, 2019 11:57AM
|
|
Zacks SCR Resverlogix Report 12/16/16
|
3
|
Resverlogix Corp.
|
Dec 20, 2016 10:34AM
|
|
Zacks SCR Resverlogix Report 11/5/18; Apabetalone: The Last Mile
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 04:51PM
|
|
Zacks SCR Resverlogix R&D Update 10/17/16
|
3
|
Resverlogix Corp.
|
Oct 18, 2016 06:37AM
|
|
Zacks SCR Report 9/19/2016
|
3
|
Resverlogix Corp.
|
Sep 21, 2016 01:21PM
|
|
Zacks SCR Report 8/2/17
|
3
|
Resverlogix Corp.
|
Aug 02, 2017 01:42PM
|
|
Zacks SCR Report 7/29/16
|
4
|
Resverlogix Corp.
|
Aug 01, 2016 11:45AM
|
|
Zacks SCR Report 6/14/17
|
5
|
Resverlogix Corp.
|
Jun 15, 2017 04:38PM
|
|
Zacks SCR Report 4/12/2018
|
3
|
Resverlogix Corp.
|
Apr 13, 2018 01:40PM
|
|
Zacks SCR Report 3/27/2017
|
7
|
Resverlogix Corp.
|
Mar 27, 2017 06:10PM
|
|
Zacks SCR Report 12/20/2017
|
4
|
Resverlogix Corp.
|
Dec 23, 2017 08:43AM
|
|
Zacks SCR 8/5/19: Targeting September Readout for BETonMACE
|
4
|
Resverlogix Corp.
|
Aug 05, 2019 11:52AM
|
|
Zacks SCR 4/2/2019: BETonMACE Final Event Expected April 2019
|
1
|
Resverlogix Corp.
|
Apr 02, 2019 04:29PM
|
|
Zacks SCR 11/4/2019: RVX.TO: SOME CLARITY ON THE PATH FORWARD
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 02:35PM
|
|
Yawn
|
4
|
Zenith Epigenetics
|
May 24, 2017 10:37AM
|
